Literature DB >> 10597679

Microsurgery costs and outcome.

T R Heinz1, P A Cowper, L S Levin.   

Abstract

Reliable information on cost and value in microsurgery is not readily available in the literature. Driving factors for cost, determinants of complications, and cost-reduction strategies have not been elucidated in this population, despite such progress in other areas of medicine. Clearly, the time-consuming and costly nature of this endeavor demands that appropriate indications and patient management be delineated; to operate proactively in this cost-conscious time, financial and outcome determinations are critical. One hundred seven consecutive free-tissue transfers performed from 1991 to 1994 by a single microsurgeon were studied. Retrospective chart review for clinical parameters was combined with analysis of hospital costs and professional charges. Operating room and anesthesia costs were based on a microcost analysis of actual operating room time, materials, labor, and overhead. Other patient level costs were generated by Transition 1, a hospital cost-accounting system. The following issues were addressed: (1) flap survival; (2) total costs and length of stay for all free flaps; (3) payments received from various insurers; (4) breakdown of operating room costs by labor, supplies, and overhead; (5) breakdown of inpatient costs by category; (6) additional costs of complications and takebacks; (7) factors associated with complications and flap takebacks; and (8) cost-reduction strategies. Mean free flap operating room costs (exclusive of professional fees) ranged among case types from $4439 to $6856 and were primarily a function of operating room times. Elective patient cases lasted a mean 440 minutes. There was a large disparity in reimbursement: private insurers covered hospital costs (not charges) completely, whereas Medicare paid 79 percent and Medicaid only 64 percent. Length of stay, operative procedures, and complications had the greatest influence on inpatient costs in this group of free flap patients. Potential cost savings as a result of possible practice changes (e.g., shortening intensive care unit stays and avoiding staged operations) can be predicted. This analysis has caused a revision in these institutions' practice patterns and lays the foundation for planned outcome studies in this population.

Entities:  

Mesh:

Year:  1999        PMID: 10597679

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

Review 1.  Economic burden of head and neck cancer. A literature review.

Authors:  Jennifer M Lee; Marco Turini; Marc F Botteman; Jennifer M Stephens; Chris L Pashos
Journal:  Eur J Health Econ       Date:  2004-02

2.  Breast reconstruction in private practice.

Authors:  Steven M Pisano; Peter R Ledoux; Chet L Nastala
Journal:  Semin Plast Surg       Date:  2004-05       Impact factor: 2.314

3.  Multicenter prospective micro-costing study evaluating mandibular free-flap reconstruction.

Authors:  Olivier Dassonville; Alexandre Bozec; Yann Château; Emile Reyt; Bernard Devauchelle; Marie-Yolande Louis; Pierre Breton; Morbize Julieron; Jacques Yachouh; Yann Mallet; Jérôme Sarini; Gilles Dolivet; Renaud Schiappa; Jocelyn Gal; Marie-Helene Orlanducci; Gilles Poissonnet; Emmanuel Chamorey
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-27       Impact factor: 2.503

4.  The role of negative pressure wound therapy in the treatment of fourth-degree burns. Trends and new horizons.

Authors:  I Sahin; M Eski; C Acikel; R Kapaj; D Alhan; S Isik
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

5.  The treatment of soft-tissue defects of the lower leg after a traumatic open tibial fracture.

Authors:  J M Franken; P Hupkens; P H M Spauwen
Journal:  Eur J Plast Surg       Date:  2010-02-27

6.  Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer.

Authors:  William R Hand; William D Stoll; Matthew D McEvoy; Julie R McSwain; Clark D Sealy; Judith M Skoner; Joshua D Hornig; Paul A Tennant; Bethany Wolf; Terry A Day
Journal:  Head Neck       Date:  2016-02-01       Impact factor: 3.147

7.  Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma.

Authors:  Arash O Naghavi; Ricardo J Gonzalez; Jacob G Scott; Youngchul Kim; Yazan A Abuodeh; Tobin J Strom; Michelle Echevarria; John E Mullinax; Kamran A Ahmed; Louis B Harrison; Daniel C Fernandez
Journal:  J Contemp Brachytherapy       Date:  2017-01-31

8.  Hyperspectral Imaging (HSI) as a new diagnostic tool in free flap monitoring for soft tissue reconstruction: a proof of concept study.

Authors:  Lukas H Kohler; Hannes Köhler; Simon Kohler; Stefan Langer; Rima Nuwayhid; Ines Gockel; Nick Spindler; Georg Osterhoff
Journal:  BMC Surg       Date:  2021-04-30       Impact factor: 2.102

9.  High-Risk Plastic Surgery: An Analysis of 108,303 Cases From the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP).

Authors:  Melissa Wan; Jacques X Zhang; Yichuan Ding; Yiwen Jin; Julie Bedford; Mahesh Nagarajan; Marija Bucevska; Douglas J Courtemanche; Jugpal S Arneja
Journal:  Plast Surg (Oakv)       Date:  2019-10-30       Impact factor: 0.947

10.  Recent conclusions regarding the reconstructive microsurgery of peripheral nerves.

Authors:  Doina Dumitrescu-Ionescu
Journal:  J Med Life       Date:  2008 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.